Sialidase-based anti-influenza virus therapy protects against secondary pneumococcal infection

Journal of Infectious Diseases

Volumn 201, Issue 7, 2010, Pages 1007-1015

  Hedlund, Maria ^a   Aschenbrenner, Laura M ^a   Jensen, Kellie ^a   Larson, Jeffrey L ^a   Fang, Fang ^a  

^a NexBio Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DAS 181; FLUDASE; HYBRID PROTEIN; SIALIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; CITROBACTER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INFECTION RISK; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; KLEBSIELLA; LETHAL DOSE; LUNG; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SECONDARY INFECTION; STREPTOCOCCUS PNEUMONIAE; SURVIVAL TIME; VIRUS INHIBITION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMOCOCCAL INFECTIONS; RECOMBINANT FUSION PROTEINS; STREPTOCOCCUS PNEUMONIAE; VIRAL LOAD;

EID: 77749306182     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/651170     Document Type: Article

References (40)

1. Hers JF, Masurel N, Mulder J. Bacteriology and histopathology of the respiratory tract and lungs in fatal Asian influenza. Lancet 1958; 2: 1141-1143
2. Lindsay MI Jr, Herrmann EC Jr, Morrow GW Jr, Brown AL Jr. Hong Kong influenza: clinical, microbiologic, and pathologic features in 127 cases. JAMA 1970;214:1825-1832
3. Louria DB, Blumenfeld HL, Ellis JT, Kilbourne ED, Rogers DE. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest 1959;38:213-265
4. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198:962-970
5. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 2008;86:408-416
6. Madhi SA, Klugman KP. A role for Streptococcus pneumoniae in virusassociated pneumonia. Nat Med 2004; 10:811-813
7. Kyaw MH, Lynfield R, Schaffner W, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006;354:1455-1463
8. Hicks LA, Harrison LH, Flannery B, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007;196:1346-1354
9. Malakhov MP, Aschenbrenner LM, Smee DF, et al. Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection. Antimicrob Agents Chemother 2006;50:1470-1479
10. Ah-Tye C, Schwartz S, Huberman K, Carlin E, Moscona A. Virusreceptor interactions of human parainfluenza viruses types 1, 2 and 3. Microb Pathog 1999;27:329-336
11. Paton JC, Andrew PW, Boulnois GJ, Mitchell TJ. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. Annu Rev Microbiol 1993;47:89-115.
12. Tuomanen E. Molecular and cellular biology of pneumococcal infection. Curr Opin Microbiol 1999;2:35-39 (Pubitemid 29130212)
13. Jedrzejas MJ. Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev 2001;65:187-207. (Pubitemid 32538177)
14. Peltola VT, McCullers JA. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J 2004;23:S87-S97.
15. Peltola VT, Murti KG, McCullers JA. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis 2005; 192:249-257
16. King SJ, Hippe KR, Weiser JN. Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae. Mol Microbiol 2006; 59:961-974
17. Tong HH, Blue LE, James MA, DeMaria TF. Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun 2000;68:921-924
18. Manco S, Hernon F, Yesilkaya H, Paton JC, Andrew PW, Kadioglu A. Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis. Infect Immun 2006; 74:4014-4020
19. Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 2004; 190:1661-1669
20. Soong G, Muir A, Gomez MI, et al. Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J Clin Invest 2006;116:2297-2305 (Pubitemid 44162340)
21. Trappetti C, Kadioglu A, Carter M, et al. Sialic acid: a preventable signal for pneumococcal biofilm formation, colonization, and invasion of the host. J Infect Dis 2009;199:1497-1505
22. King QO, Lei B, Harmsen AG. Pneumococcal surface protein A contributes to secondary Streptococcus pneumoniae infection after influenza virus infection. J Infect Dis 2009;200:537-545
23. McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis 2003; 187:1000-1009
24. Nicholls JM, Aschenbrenner LM, Paulson JC, et al. Comment on: concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza. J Antimicrob Chemother 2008; 62:426-428 (Pubitemid 351984794)
25. 25. McCullers JA. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. J Infect Dis 2004; 190:519-526 (Pubitemid 38982091)
26. van der Sluijs KF, van Elden LJ, Nijhuis M, et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol 2004;172:7603-7609 (Pubitemid 38747624)
27. Bleich A, Kirsch P, Sahly H, et al. Klebsiella oxytoca: opportunistic infections in laboratory rodents. Lab Anim 2008;42:369-375
28. Lipsky BA, Hook EW III, Smith AA, Plorde JJ. Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature. Rev Infect Dis 1980;2:746-760
29. McCullers JA, Tuomanen EI. Molecular pathogenesis of pneumococcal pneumonia. Front Biosci 2001;6:D877-89.
30. McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 2002; 186:341-350
31. Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000; 181:831-837
32. Peltola VT, Boyd KL, McAuley JL, Rehg JE, McCullers JA. Bacterial sinusitis and otitis media following influenza virus infection in ferrets. Infect Immun 2006; 74:2562-2567
33. Giebink GS, Wright PF. Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas. Infect Immun 1983;41:913-920
34. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 146:1067-1083
35. Wilson R, Cole PJ. The effect of bacterial products on ciliary function. Am Rev Respir Dis 1988;138:S49-S53.
36. LeVine AM, Koeningsknecht V, Stark JM. Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice. J Virol Methods 2001;94:173-186
37. van der Sluijs KF, Nijhuis M, Levels JH, et al. Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. J Infect Dis 2006; 193:214-222
38. Walsh JJ, Dietlein LF, Low FN, Burch GE, Mogabgab WJ. Bronchotracheal response in human influenza. Type A, Asian strain, as studied by light and electron microscopic examination of bronchoscopic biopsies. Arch Intern Med 1961; 108:376-388
39. Plotkowski MC, Puchelle E, Beck G, Jacquot J, Hannoun C. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. Am Rev Respir Dis 1986; 134:1040-1044
40. Chandrasekaran A, Srinivasan A, Raman R, et al. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol 2008;26:107-113